Dirk Schadendorf, MD, University Hospital Essen
Advertisement
Articles by Dirk Schadendorf, MD, University Hospital Essen
Advertisement
Latest Updated Articles
Molecular Testing in Metastatic MelanomaJanuary 22nd 2021
The Role of COVID-19 in Adjuvant Treatment Decisions in MelanomaJanuary 22nd 2021
Looking at Approved Agents in Metastatic MelanomaJanuary 29th 2021
Testing and BRAF Mutations in MelanomaJanuary 8th 2021
Future Directions in Metastatic MelanomaFebruary 5th 2021
A Look at the KEYNOTE-054 and COMBI-AD DataJanuary 15th 2021
Advertisement
Advertisement
Trending on OncLive
1
FDA Advisory Committee to Weigh RP1 Plus Nivolumab in Anti–PD-1–Pretreated Advanced Melanoma
2
FDA Grants RMAT and Fast Track Designations to Cema-Cel for First-Line LBCL
3
Dr Hashmi on the Identification of Candidates for CAR T-Cell Therapy in Early R/R Myeloma
4
Dr Secord on Combining Mocertatug Rezetecan With Dostarlimab in Endometrial Cancer
5